Revolution Medicines logo

Executive Director, Global Forecasting

Revolution Medicines

Redwood City, CAHybridPosted 2 days ago$252,000 - $315,000/year
Full TimeDirector & AboveCommercial & Pharma SalesBiotechnology
Original posting ↗

Summary

Reporting to the Vice President, Global Analytics & Insights, the Executive Director, Global Forecasting will lead the global forecasting function across disease areas and the portfolio, from preclinical and Phase 1 assets through commercialization. The role directly manages three Senior Directors spanning disease area forecasting and portfolio forecasting methods, systems and analytics, and develops the teams and capabilities needed to support an expanding portfolio. This leader will integrate forecasts and scenarios into a coherent view of opportunity, demand and risk, informing development, lifecycle, investment and commercial decisions. Working with global and regional partners, the Executive Director will establish shared forecasting standards, align priorities and translate uncertainty into clear recommendations for senior leadership. This position is based at our headquarters in Redwood City, CA.

Job description

The Opportunity

Reporting to the Vice President, Global Analytics & Insights, the Executive Director, Global Forecasting will lead the global forecasting function across disease areas and the portfolio, from preclinical and Phase 1 assets through commercialization. The role directly manages three Senior Directors spanning disease area forecasting and portfolio forecasting methods, systems and analytics, and develops the teams and capabilities needed to support an expanding portfolio. This leader will integrate forecasts and scenarios into a coherent view of opportunity, demand and risk, informing development, lifecycle, investment and commercial decisions. Working with global and regional partners, the Executive Director will establish shared forecasting standards, align priorities and translate uncertainty into clear recommendations for senior leadership. This position is based at our headquarters in Redwood City, CA.

Responsibilities

  • Set the global forecasting strategy, operating model and priorities across early products, later-stage programs and commercial assets. Align resources and delivery with critical business decisions and planning cycles.
  • Directly manage, coach and develop three Senior Directors and their teams.
  • Establish clear accountabilities across disease area forecasting and portfolio methods, systems and analytics; build leadership capacity and manage functional budgets and vendors.
  • Oversee global patient-based, revenue and demand forecasts, integrating regional inputs into a consistent portfolio view.
  • Agree with regional leaders, Finance and Supply Chain the ownership, review and approval of forecasts for each planning purpose.
  • Challenge key assumptions and ensure analytical rigor, with transparent regional perspectives and unresolved differences.
  • Lead forecasting contributions to cross-portfolio scenario planning with Disease Area Insights and Data & Analytics.
  • Assess overlapping populations, treatment sequencing, combinations, launch timing and product interactions to quantify incremental opportunity and avoid double counting.
  • Establish a shared global and regional framework for methodologies, core assumptions, scenarios, documentation and review, agreed with regional forecasting leaders.
  • Ensure meaningful differences are reconciled or clearly explained with evidence and implications for planning, with an agreed process for justified local adaptations.
  • Oversee forecasting model design, methodologies, consolidation logic and analytical requirements.
  • Partner with Data & Analytics and Information Systems on shared data infrastructure and platform delivery.
  • Guide adoption of probabilistic methods, sensitivity analyses and decision frameworks where they improve assessment of uncertainty, interdependencies and decision thresholds.
  • Partner with Finance and Supply Chain to provide forecasts and scenarios for long-range plans, budgets, launch readiness, supply and capacity planning, and ongoing commercial and demand planning.
  • Ensure transparent translation of patient, treatment duration and utilization assumptions into revenue and demand, with clear bridges explaining differences between strategic, operating and supply planning views.
  • Provide forecasting leadership for early product assessments, development and lifecycle options, portfolio prioritization and go/no-go decisions.
  • Quantify scenarios and value drivers using commercial evidence led by Disease Area Insights and analytical inputs from Data & Analytics, contributing to the integrated A&I recommendation led by the Vice President.
  • Support Business and Corporate Development and Commercial Partnerships with business cases, scenarios and independent assessment of assumptions.
  • Partner with Disease Area Insights, Data & Analytics, Commercial, Clinical Development, Medical Affairs, Market Access and Portfolio Strategy to incorporate evidence, competitive developments and market dynamics into forecasts and strategic recommendations.
  • Coordinate with regional forecasting leaders to agree priorities, ownership, support and transitions based on local capabilities and needs.
  • Provide expertise and practical support through the team, strengthen local capabilities and facilitate reuse of tools and effective practices.
  • Agree capacity, service expectations and readiness criteria for transitions, maintaining continuity of support.
  • Establish forecast review and quality assurance processes, including model validation, version control, assumption traceability and analysis of forecast changes.
  • Incorporate actual performance and emerging evidence to improve forecasts over time, evaluating forecast accuracy and bias at appropriate horizons and explaining their drivers.
  • Present integrated forecasts, ranges, risks and strategic implications to senior leadership.
  • Resolve cross-functional differences where possible and elevate material tradeoffs and unresolved assumptions for decisions.
  • Travel domestically and internationally as needed, typically up to 25–30%.

Required Skills, Experience and Education

  • Bachelor’s degree with 15+ years of progressive experience in biotechnology, pharmaceuticals or consulting, including substantial experience leading forecasting in oncology.
  • Experience managing senior leaders and managers, developing teams and scaling forecasting capabilities in a growing organization.
  • Deep expertise in patient-based forecasting, portfolio scenarios and risk analysis across early development, launch and commercial stages, including interactions among multiple products and indications.
  • Experience translating forecasts into long-range plans, supply requirements, portfolio investment decisions and business opportunity assessments.
  • Experience establishing shared methods, governance and systems across global and regional teams while accommodating justified market differences.
  • Strong analytical judgment and business acumen, with the ability to challenge assumptions, communicate uncertainty and influence senior leadership and cross-functional partners.
  • Ability to prioritize competing needs, work effectively through ambiguity and combine functional leadership with direct contributions to critical business questions.

Preferred Skills

  • Advanced degree in a quantitative, scientific or business discipline.
  • Experience launching targeted oncology therapies globally and supporting business development or commercialization partnerships.
  • Experience applying advanced analytics and probabilistic methods to portfolio forecasting and decision making.

Requirements

  • Bachelor’s degree with 15+ years of progressive experience in biotechnology, pharmaceuticals or consulting, including substantial experience leading forecasting in oncology
  • Experience managing senior leaders and managers, developing teams and scaling forecasting capabilities in a growing organization
  • Deep expertise in patient-based forecasting, portfolio scenarios and risk analysis across early development, launch and commercial stages, including interactions among multiple products and indications
  • Experience translating forecasts into long-range plans, supply requirements, portfolio investment decisions and business opportunity assessments
  • Experience establishing shared methods, governance and systems across global and regional teams while accommodating justified market differences
  • Strong analytical judgment and business acumen, with the ability to challenge assumptions, communicate uncertainty and influence senior leadership and cross-functional partners
  • Ability to prioritize competing needs, work effectively through ambiguity and combine functional leadership with direct contributions to critical business questions
  • Advanced degree in a quantitative, scientific or business discipline
  • Experience launching targeted oncology therapies globally and supporting business development or commercialization partnerships
  • Experience applying advanced analytics and probabilistic methods to portfolio forecasting and decision making

Benefits

  • Competitive cash compensation
  • Equity awards
  • Health benefits
  • Learning and development opportunities

Company overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.